SciFi Futures
← Concepts
Biotech & Medicine

Cryosleep for interstellar flight

Crew held in frozen or deeply hypometabolic sleep for years to decades of flight, revived on arrival, with a small per-passage chance of not waking up.

In shortCryosleep for interstellar flight, from Revelation Space (Alastair Reynolds, 2000), Methuselah's Children (Robert A. Heinlein, 1958) and Blindsight (Peter Watts, 2006), is at technology readiness level 2 of 9 (technology concept formulated) at its weakest link. Held back by Reversible whole-body cryopreservation. Science status: consistent with known physics; key effects unproven at scale. Estimated new funding to unlock: $5.5B–25B (a floor; some parts are priced only to early research).

Reefersleep is routine aboard Ultra lighthuggers - crew and passengers are frozen for decades-long crossings, with reefersleep deaths and revival complications treated as an accepted statistical cost.
Revelation Space by Alastair Reynolds, 2000Set in 2566On track540 years left to climb 6 TRL steps (90.0 yrs/step)
Most of the New Frontiers' emigrants spend the interstellar voyage in suspended animation while a skeleton crew stays awake.
Methuselah's Children by Robert A. Heinlein, 1958Set in 2136On track110 years left to climb 6 TRL steps (18.3 yrs/step)
The Theseus crew travel "undead", dormant via gene retrofits borrowed from resurrected vampires' hibernation biology, and wake "in an agony of resurrection".
Blindsight by Peter Watts, 2006Set in 2082On track56 years left to climb 6 TRL steps (9.3 yrs/step)

Closest todayReversible torpor-like states are demonstrated in rodents, deep-hypothermic circulatory arrest buys under an hour clinically, and a vitrified rat kidney has been recovered after 100 days - no mammal has been frozen whole and revived.

Dependency stack

Research TRL 1–3Development TRL 4–6Deployment TRL 7–9
Sort by
  • Years of storage below the glass transition and functional revival is the literal requirement
    • Cryoprotectant must reach every tissue through a circulation that stops working as it cools
    • Different tissues need different agent concentrations and cooling rates, so no single protocol fits a whole body
    • Rewarming a 70 kg body uniformly faster than devitrification has no demonstrated mechanism
    • Whole-brain functional recovery after vitrification has never been shown in any species
    plausibleTRL 2
    • A body is a set of organs that must each survive the same protocol
      ✕4 blockers›
      • Rewarming rate must exceed the devitrification threshold everywhere at once - heating uniformity gets worse with volume
      • Thermal-stress cracking appears in organ-scale samples below the glass transition
      • Nanoparticle loading and complete post-warming washout are unproven in large vasculature
      • Brain has never been vitrified and recovered functionally in any species
      TRL 4
      • Vitrification only happens if ice is suppressed throughout the tissue
        ✕3 blockers›
        • Cryoprotectant concentrations that prevent ice (over 50 percent w/v) are chemically toxic over the hours needed to load a large organ
        • Perfusion is uneven - poorly vascularized regions receive too little agent and nucleate ice
        • Devitrification during rewarming happens faster than agents can suppress in large volumes
        TRL 5
        • Designed ice-binding and antifreeze proteins are the main route to blocking ice at lower chemical toxicity
          ✕1 blocker›
          • Designing catalysis and conformational dynamics
          TRL 6
    • The brain is the organ whose information must survive, and it sets the protocol's hardest constraint
      ✕3 blockers›
      • Ischemic damage starts within minutes of circulatory arrest, before perfusion can begin
      • Aldehyde fixation may destroy molecular state (phosphorylation, receptor conformation) that could carry memory
      • No assay proves preserved tissue still contains the information an emulation would need
      TRL 4
    • Whole-body loading needs far lower toxicity per unit ice suppression than organ work does
      TRL 5
  • Every organ must survive the same cooling and rewarming protocol, which is only shown at rat-kidney scale
    TRL 4
  • Deep hypometabolism rather than freezing is the nearer-term route to multi-year transit, and is the state an entry or exit protocol passes through
    ✕4 blockers›
    • No demonstration in any nonhuman primate, so species transfer is unproven
    • Cardiac arrhythmia and coagulopathy risk rises steeply below about 30 C core temperature
    • Weeks-long torpor still implies muscle and bone loss, parenteral nutrition and immune suppression
    • Arousal is the dangerous phase - rewarming injury and reperfusion damage are uncontrolled
    TRL 4
    • You cannot induce a state whose controlling circuit is unmapped in primates
      ✕3 blockers›
      • Unknown whether primates retain a latent torpor circuit or only a fever/heat-loss circuit
      • Multi-week metabolic suppression is unmapped - all demonstrations last hours to days
      • Torpor entry and arousal involve coordinated cardiac, renal and immune changes that are not individually controllable
      TRL 3
    • A torpid crew still needs atmosphere, water and waste handling with no one awake
      ✕2 blockers›
      • Food production closure
      • Microbial and ecological stability over years
      TRL 5
  • Ice must be suppressed body-wide at concentrations a living person survives
    TRL 5
  • Sleepers still need atmosphere, power and waste handling for decades with nobody awake
    TRL 5
  • Entry, monitoring and revival happen with no clinician aboard
    ✕4 blockers›
    • Demonstrations use cadaveric or marked tissue - bleeding, smoke and deforming live anatomy are untested
    • No perception system reliably identifies critical structures (duct versus artery) at the certainty surgery requires
    • Diagnosis, anesthesia and post-operative management remain outside the loop, so the system is not a self-contained doctor
    • No regulatory pathway exists for a device making irreversible intraoperative decisions
    TRL 5
    • Tissue handling, clipping and suturing demand fine force-controlled manipulation
      ✕2 blockers›
      • Robot training data at scale
      • Tactile sensing and robust hands
      TRL 5
      • Fine force control and slip detection need touch
        ✕3 blockers›
        • Elastomer skins wear out and need recalibration after thousands of contacts
        • Wiring and bandwidth for thousands of taxels across a whole hand
        • Few large tactile datasets to train manipulation policies
        TRL 5
      • Generalist perception and planning
        ✕2 blockers›
        • Reliability and calibration over long horizons
        • Continual learning after deployment
        TRL 7
        • Training and inference compute
          ✕2 blockers›
          • Grid power and interconnection queues
          • Advanced-node chip and HBM memory supply
          TRL 8
    • Safe autonomy needs to see structures beneath the exposed surface
      ✕3 blockers›
      • Optical scattering caps high-resolution imaging at a few millimetres of tissue depth
      • MRI gives depth but not video-rate cell-scale resolution, and excludes magnetic actuation hardware
      • Tracking swarms rather than single objects has no demonstrated method
      TRL 5
    • Task decomposition and language-conditioned policies are what made autonomous phases work
      TRL 7

Who could unlock it

  • Across several requirements:
  • John Bischof 3
  • 21st Century Medicine 2
  • NSF ATP-Bio 2
  • Shannon Tessier 2
Reversible whole-body cryopreservationTRL 2bottleneck
  • Greg FahyResearcher, 21st Century Medicine
    Developed the M22 cryoprotectant and reported in 2026 ultrastructural and histological preservation of whole mammalian brains by vitrification without aldehyde fixation
  • 21st Century MedicineCompany
    The only company doing primary cryobiology research toward reversible preservation; won the Brain Preservation Foundation small mammal prize for aldehyde-stabilised cryopreservation
  • Brain Preservation FoundationProgram
    Set and judged the small and large mammal brain preservation prizes, which remain the only independent benchmarks in the field
  • Alcor Life Extension FoundationCompany
    Performs whole-body procedures today at roughly 220 thousand dollars (neuro 80 to 90 thousand), all one-way, with no claim of demonstrated reversibility
Organ vitrification and uniform rewarmingTRL 4
  • John BischofResearcher, University of Minnesota
    Directs NSF ATP-Bio and led the September 2026 result vitrifying human-scale pig kidneys for up to 366 days with function recovered on transplant
  • NSF ATP-BioProgram
    NSF Engineering Research Center (EEC-1941543) co-led by Minnesota and Mass General Brigham, pairing the PEZ42 cryoprotectant with radiofrequency nanowarming
  • Erik FingerResearcher, University of Minnesota
    Transplant surgeon who reperfused the nanowarmed pig kidneys in 2026 and reported urine output on the operating table
  • Mehmet TonerResearcher, Massachusetts General Brigham and Harvard Medical School
    Deputy director of ATP-Bio, supplying the microfluidic and biopreservation side of the organ-banking effort
Induced torpor in humansTRL 4
  • Matteo CerriResearcher, University of Bologna
    Induced synthetic torpor in rats, which do not naturally enter it, by inhibiting raphe pallidus neurons, and chairs the ESA topical team working toward healthy-volunteer tests
  • Hong ChenResearcher, Washington University in St. Louis
    Used focused ultrasound on the hypothalamic preoptic area to hold mice in a torpor-like state for up to 24 hours, and induced it in rats (Nature Metabolism, 2023)
  • European Space AgencyProgram
    Funds the hibernation topical team and the mission-architecture studies that assume a torpid crew, through its human and robotic exploration research programme
  • NASAProgram
    Building rodent torpor flight hardware and studying natural hibernators for space health, the only agency effort aimed at orbital validation
Low-toxicity vitrification agentsTRL 5
  • John BischofResearcher, University of Minnesota
    Directs NSF ATP-Bio; his group's iron-oxide nanowarming plus M22-class cocktails enabled recovery of vitrified rat kidneys (2023) and, with MGH, the first transplant of a cryopreserved large-mammal kidney
  • NSF ATP-Bio Engineering Research CenterProgram
    NSF Engineering Research Center (grant EEC-1941543) co-led by the University of Minnesota and Mass General Brigham; its Year 4 report cites $30M of leveraged non-ERC funding and it was the only ERC highlighted in NSF's FY2027 budget request
  • Until LabsStartup
    Building reversible organ cryopreservation end to end; reported expanding its cryoprotectant discovery engine from dozens to over 250,000 candidate molecules (2026) alongside organ-scale magnetic rewarming
  • Shannon TessierResearcher, Massachusetts General Hospital
    Developed partial-freezing and supercooling protocols, including non-metabolisable sugar plus ice-nucleation storage that kept human livers viable for days (2023)

Beyond engineering

  • Informed consent to a procedure with a known per-passage mortality rate
  • Liability and legal status of a person stored for decades mid-voyage